Antidiarrheal, anticaries final monographs lead FDA priority list of OTC publications.
This article was originally published in The Tan Sheet
Executive Summary
ANTIDIARRHEAL, ANTICARIES FINAL MONOGRAPHS LEAD PRIORITY LIST of over-the-counter drug regulatory documents in the works at FDA, according to the agency's "unified agenda," published in the May 8 Federal Register. The final monograph on OTC antidiarrheal products is the closest to publication, according to the timetable.